Search Results - "Cross, Michael J."

Refine Results
  1. 1

    Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues by Ravenscroft, Stephanie M, Pointon, Amy, Williams, Awel W, Cross, Michael J, Sidaway, James E

    Published in Toxicological sciences (01-07-2016)
    “…The immature phenotype of stem cell derived cardiomyocytes is a significant barrier to their use in translational medicine and pre-clinical in vitro drug…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Phenotypic profiling of structural cardiotoxins in vitro reveals dependency on multiple mechanisms of toxicity by Pointon, Amy, Abi-Gerges, Najah, Cross, Michael J, Sidaway, James E

    Published in Toxicological sciences (01-04-2013)
    “…Morphological damage to cardiomyocytes or loss of viability (structural cardiotoxicity) is a common cause of attrition in preclinical and clinical drug…”
    Get full text
    Journal Article
  4. 4

    Umbilical cord mesenchymal stromal cell-derived extracellular vesicles lack the potency to immunomodulate human monocyte-derived macrophages in vitro by da Silva, Tamiris Borges, Rendra, Erika, David, Christopher A.W., Bieback, Karen, Cross, Michael J., Wilm, Bettina, Liptrott, Neill J., Murray, Patricia

    Published in Biomedicine & pharmacotherapy (01-11-2023)
    “…Mesenchymal stromal cells (MSCs) have been reported to display efficacy in a variety of preclinical models, but without long-term engraftment, suggesting a…”
    Get full text
    Journal Article
  5. 5

    Cardiotoxic drugs Herceptin and doxorubicin inhibit cardiac microvascular endothelial cell barrier formation resulting in increased drug permeability by Wilkinson, Emma L, Sidaway, James E, Cross, Michael J

    Published in Biology open (15-10-2016)
    “…Cardiotoxicity induced by anti-cancer therapeutics is a severe, and potentially fatal, adverse reaction of the heart in response to certain drugs. Current in…”
    Get full text
    Journal Article
  6. 6

    Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway by Tomlinson, Lauren, Lu, Zhen Qi, Bentley, Robert A, Colley, Helen E., Murdoch, Craig, Webb, Steven D., Cross, Michael J., Copple, Ian M., Sharma, Parveen

    Published in Biomedicine & pharmacotherapy (01-04-2019)
    “…[Display omitted] •Cardiac damage is a major adverse reaction in the treatment of cancer patients.•After secondary malignancy cardiovascular disease major…”
    Get full text
    Journal Article
  7. 7

    The role of ERK5 in endothelial cell function by Nithianandarajah-Jones, Gopika N, Wilm, Bettina, Goldring, Christopher E P, Müller, Jürgen, Cross, Michael J

    Published in Biochemical Society transactions (01-12-2014)
    “…Extracellular-signal-regulated kinase 5 (ERK5), also termed big MAPK1 (BMK1), is the most recently discovered member of the mitogen-activated protein kinase…”
    Get more information
    Journal Article
  8. 8

    Extracellular Vesicles from Human Umbilical Cord-Derived MSCs Affect Vessel Formation In Vitro and Promote VEGFR2-Mediated Cell Survival by Muñiz-García, Ana, Wilm, Bettina, Murray, Patricia, Cross, Michael J

    Published in Cells (Basel, Switzerland) (24-11-2022)
    “…Mesenchymal stromal cell (MSC)-derived extracellular vesicles (EVs) have emerged as novel tools in regenerative medicine. Angiogenesis modulation is widely…”
    Get full text
    Journal Article
  9. 9

    Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells by Koukorava, Chrysa, Ahmed, Katie, Almaghrabi, Shrouq, Pointon, Amy, Haddrick, Malcolm, Cross, Michael J

    Published in Frontiers in cardiovascular medicine (11-07-2024)
    “…Cardiotoxicity can be defined as "chemically induced heart disease", which can occur with many different drug classes treating a range of diseases. It is the…”
    Get full text
    Journal Article
  10. 10

    ERK5 and the regulation of endothelial cell function by Roberts, Owain Llŷr, Holmes, Katherine, Müller, Jürgen, Cross, Darren A E, Cross, Michael J

    Published in Biochemical Society transactions (01-12-2009)
    “…ERK5 (extracellular-signal-regulated kinase 5), also termed BMK1 [big MAPK1 (mitogen-activated protein kinase 1)], is the most recently discovered member of…”
    Get more information
    Journal Article
  11. 11

    Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis by Mellberg, Sofie, Dimberg, Anna, Bahram, Fuad, Hayashi, Makoto, Rennel, Emma, Ameur, Adam, Westholm, Jakub Orzechowski, Larsson, Erik, Lindahl, Per, Cross, Michael J, Claesson-Welsh, Lena

    Published in The FASEB journal (01-05-2009)
    “…To define molecular events accompanying formation of the 3-dimensional (3D) vascular tube, we have characterized gene expression during vascular endothelial…”
    Get full text
    Journal Article
  12. 12

    N-Heterocyclic Carbenes as Highly Efficient Catalysts for the Cyclotrimerization of Isocyanates by Duong, Hung A, Cross, Michael J, Louie, Janis

    Published in Organic letters (09-12-2004)
    “…A series of N-heterocyclic carbenes (NHCs) were evaluated as potential catalysts for the cyclotrimerization of isocyanates to afford isocyanurates…”
    Get full text
    Journal Article
  13. 13

    VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta by Holmes, Katherine, Chapman, Elinor, See, Violaine, Cross, Michael J

    Published in PloS one (06-07-2010)
    “…Vascular endothelial growth factor (VEGF) has previously been shown to upregulate the expression of the endogenous calcineurin inhibitor, regulator of…”
    Get full text
    Journal Article
  14. 14

    Nickel-Catalyzed Cycloaddition of Alkynes and Isocyanates by Duong, Hung A, Cross, Michael J, Louie, Janis

    Published in Journal of the American Chemical Society (22-09-2004)
    “…A mild and general route for preparing 2-pyridones from isocyanates and diynes is described. Ni imidazolyidene complexes were used to mediate cyclizations…”
    Get full text
    Journal Article
  15. 15

    Mesothelial Cells Exhibit Characteristics of Perivascular Cells in an In Vitro Angiogenesis Assay by Koukorava, Chrysa, Ward, Kelly, Ahmed, Katie, Almaghrabi, Shrouq, Dauleh, Sumaya, Pereira, Sofia M, Taylor, Arthur, Haddrick, Malcolm, Cross, Michael J, Wilm, Bettina

    Published in Cells (Basel, Switzerland) (01-10-2023)
    “…Mesothelial cells have been shown to have remarkable plasticity towards mesenchymal cell types during development and in disease situations. Here, we have…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    ERK5 is required for VEGF-mediated survival and tubular morphogenesis of primary human microvascular endothelial cells by Roberts, Owain Llŷr, Holmes, Katherine, Müller, Jürgen, Cross, Darren A.E, Cross, Michael J

    Published in Journal of cell science (15-09-2010)
    “…Extracellular signal-regulated kinase 5 (ERK5) is activated in response to environmental stress and growth factors. Gene ablation of Erk5 in mice is…”
    Get full text
    Journal Article
  19. 19

    Analysis of VEGF-Mediated ERK5 Activity in Endothelial Cells by Nithianandarajah-Jones, Gopika N, Cross, Michael J

    “…Extracellular signal-regulated kinase 5 (ERK5), also known as big MAPK (BMK1), is the most recently identified member of the mitogen-activated kinase pathway…”
    Get more information
    Journal Article
  20. 20

    Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition by Holmes, Katherine, Roberts, Owain Ll, Thomas, Angharad M., Cross, Michael J.

    Published in Cellular signalling (01-10-2007)
    “…Vascular endothelial growth factors (VEGFs) regulate vascular development, angiogenesis and lymphangiogenesis by binding to a number of receptors. VEGFR-1 is…”
    Get full text
    Journal Article